Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Globus Medical (GMED)
NYSE:GMED
Holding GMED?
Track your performance easily
GMED Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$44.02 - $85.01
Previous Close$84.91
Volume966.61K
Average Volume (3M)794.17K
Market Cap
$11.56B
Enterprise Value$12.02B
Total Cash (Recent Filing)$71.94M
Total Debt (Recent Filing)$534.56M
Price to Earnings (P/E)128.1
Beta1.13
Next Earnings
Feb 20, 2025EPS Estimate
$0.74Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.66
Shares Outstanding136,167,342
10 Day Avg. Volume1,163,080
30 Day Avg. Volume794,166
Standard Deviation0.10
R-Squared0.36
Alpha-0.00330
Financial Highlights & Ratios
Price to Book (P/B)2.80
Price to Sales (P/S)4.58
Price to Cash Flow (P/CF)13.90
P/FCF Ratio17.50
Enterprise Value/Market CapN/A
Enterprise Value/Revenue4.85
Enterprise Value/Gross Profit11.79
Enterprise Value/Ebitda21.02
Forecast
1Y Price Target
$89.20Price Target Upside5.29% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering12
Globus Medical News
Bulls Say, Bears Say
Bulls Say
Cost EfficiencyGMED is implementing manufacturing efficiencies, gearing up for insourcing, which should drive cost savings in years 2 and 3 of its plan.
Financial PerformanceGMED continued its strength from earlier quarters into the Q3 with a significant top- and bottom-line beat driving record FCF and raising of guidance.
Product DevelopmentGMED has remained prolific from an R&D perspective, launching 4 new products in the Q3 including its first freehand navigation solution, Excelsius Navigation Hub.
Bears Say
Increased CompetitionTwo large players recently received FDA approval for their Spine robots, which adds competition for GMED.
Merger And Integration ChallengesMerging two sizable organizations with different geographic footprints, sales forces, profitability profiles, cultures, and potentially strategic foci historically could lead to some choppiness as the integration proceeds.
Regulatory RisksIf the company failed to address the FDA’s issues and there were repeat violations during another inspection, then the company would face potentially greater regulatory consequences.
---
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
GMED FAQ
What was Globus Medical’s price range in the past 12 months?
Globus Medical lowest stock price was $44.02 and its highest was $85.01 in the past 12 months.
What is Globus Medical’s market cap?
Currently, no data Available
When is Globus Medical’s upcoming earnings report date?
Globus Medical’s upcoming earnings report date is Feb 20, 2025 which is in 89 days.
How were Globus Medical’s earnings last quarter?
Globus Medical released its earnings results on Nov 05, 2024. The company reported $0.83 earnings per share for the quarter, beating the consensus estimate of $0.647 by $0.183.
Is Globus Medical overvalued?
According to Wall Street analysts Globus Medical’s price is currently Undervalued.
Does Globus Medical pay dividends?
Globus Medical does not currently pay dividends.
What is Globus Medical’s EPS estimate?
Globus Medical’s EPS estimate is $0.74.
How many shares outstanding does Globus Medical have?
Globus Medical has 113,737,240 shares outstanding.
What happened to Globus Medical’s price movement after its last earnings report?
Globus Medical reported an EPS of $0.83 in its last earnings report, beating expectations of $0.647. Following the earnings report the stock price went up 9.434%.
Which hedge fund is a major shareholder of Globus Medical?
Among the largest hedge funds holding Globus Medical’s share is Fisher Asset Management LLC. It holds Globus Medical’s shares valued at 26M.
---
Globus Medical Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$89.20 (5.29% Upside)
$89.20 (5.29% Upside)
Blogger Sentiment
Bullish
GMED Sentiment 100%
Sector Average 72%
Sector Average 72%
Hedge Fund Trend
Decreased
By 99.2K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $2.8M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▼ 2.0%
Last 30 Days ▲ 8.7%
Last 30 Days ▲ 8.7%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
84.94%
12-Months-Change
Fundamentals
Return on Equity
2.22%
Trailing 12-Months
Asset Growth
-5.04%
Trailing 12-Months
Company Description
Globus Medical
Globus Medical, Inc. operates as a medical device company that develops and commercializes healthcare solutions. The firm engages in developing products that promote healing in patients with musculoskeletal disorders. It classifies products into Innovative Fusion and Disruptive Technology. It operates through the United States and International geographical segments. The company was founded by David C. Paul, David D. Davidar and Andrew Iott in March 2003 and is headquartered in Audubon, PA.
---
GMED Earnings Call
Q3 2024
0:00 / 0:00
---
GMED Net sales Breakdown
92.34% Musculoskeletal Solutions
7.66% Enabling Technologies
---
GMED Stock 12 Month Forecast
Average Price Target
$89.20
▲(5.29% Upside)
Technical Analysis
Best Analysts Covering GMED
1 Year
1 Year Success Rate
23/29 ratings generated profit
1 Year Average Return
+20.83%
reiterated a buy rating 16 days ago
Copying Matt Miksic's trades and holding each position for 1 Year would result in 79.31% of your transactions generating a profit, with an average return of +20.83% per trade.
---